<DOC>
	<DOCNO>NCT00567593</DOCNO>
	<brief_summary>The purpose study determine effect rosiglitazone gene colon</brief_summary>
	<brief_title>Gene Regulation Thiazolidinediones</brief_title>
	<detailed_description>The primary aim study examine effect rosiglitazone ( Avandia ) gene regulation colonic epithelium absence pathologic acute chronic intestinal inflammation . The secondary aim determine effect rosiglitazone ( Avandia ) therapy T cell activation cytokine expression absence pathologic acute chronic intestinal inflammation .</detailed_description>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<mesh_term>2,4-thiazolidinedione</mesh_term>
	<criteria>Capable give informed consent Agrees use barrier method birth control duration study History inflammatory bowel disease Has take prescription counter medication two week prior enrollment History diabetes , heart failure , angina , hypertension , coronary heart disease , cancer , bleed disorder , HIV , AIDS Fasting LDL &gt; 160 mg/dl History smoking year prior enrollment Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>